Combination of photodynamic therapy + immunotherapy + chemotherapy in murine leukiemia

Neoplasma

Volumn 57, Issue 2, 2010, Pages 184-188

  Canti, G ^a   Calastretti, A ^a   Bevilacqua, A ^a   Reddi, E ^b   Palumbo, G ^c   Nicolin, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Chemotherapy; Combined therapy; Immunotherapy; L1210 murine leukemia; Photodynamic therapy

Indexed keywords

CELL THERAPY AGENT; CISPLATIN; NAVELBINE; TEMOPORFIN; ANTINEOPLASTIC AGENT;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; IN VIVO STUDY; LOW DRUG DOSE; LOW LEVEL LASER THERAPY; LYMPHOCYTE; MALE; MOUSE; MURINE LEUKEMIA; NONHUMAN; PHOTODYNAMIC THERAPY; SPLEEN CELL; TUMOR IMMUNITY; ANIMAL; BAGG ALBINO MOUSE; DBA MOUSE; DRUG EFFECT; IMMUNOLOGY; LASER; LEUKEMIA L 1210; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHOTOCHEMOTHERAPY; RADIATION EXPOSURE; SURVIVAL RATE;

ANIMALS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; IMMUNOTHERAPY, ADOPTIVE; LASERS; LEUKEMIA L1210; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; PHOTOCHEMOTHERAPY; SURVIVAL RATE;

EID: 77953623469     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_02_184     Document Type: Article

References (26)

1. DOIRON D.R., KELLER G.S Porphyrin photodynamic therapy: principles and clinical application. Curr.Probl. Derm. 1986; 15: 85-93.
2. DOUGHERTY T. J Photosensitisation of malignant tumors. Sem. Surg. Oncol. 1986; 2: 24-37. doi:10.1002/ ssu.2980020104
3. OCHSNER M. Photophisical and photobiological processes in the photodynamic therapy of tumors, J. Photochem. Photobiol, 1997; 39: 1-18. doi:10.1016/S1011-1344(96)07428-3
4. MC CAUGHAN J.S., HICKS W., LAUFMAN L., MAY E., ROACH R. Palliation of esophageal malignancy with PDT. Cancer 1984; 54: 2905-2910. doi:10.1002/1097-0142(19841 215)54:12<2905::AID-CNCR2820541215>3.0.CO;2-N
5. EDELL E.S., CORTESE D.A. Bronchoscopy phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: a 5 years experience. Mayo Clinic Proc. 1987; 62: 8-14.
6. BENSON R.C. Laser photodynamic therapy for bladder cancer. Mayo Clinic Proc. 1986; 61: 859-864.
7. T.J. DOUGHERTY, G. LAWRENCE, J.H. KAUFMAN, BOYLE D. WEISHAUPT K.R. et al. Photoradiation in the treatment of recurrent breast carcinoma. J. Natl. Cancer Inst. 1979; 62: 231-237.
8. ROBERTS W.G., SMITH K. M, MCCULLOGH J. L, BERNS M.W. Skin photosensitivity and photodestruction of several potential photodynamic sensitizers. Photochem. and Photobiol. 1989; 49: 431-438 doi:10.1111/j.1751-1097.1989. tb09191.x
9. SHUMAKER B.P. and HETZEL F.W. Clinical laser photodynamic therapy in the treatment of bladder cancer. Photochem. and Photobiol. 1987; 46: 899-901 doi:10.1111/j.1751-1097.1987.tb04866.x
10. GOMER C.J., LUNA M., FERRARIO A. Cellular targets and molecular responses associated with photodynamic therapy J. Clin. Laser Med. Surg. 1996; 14: 315-321.
11. EVANS S., MATTHEWS W., PERRY R. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages J. Natl. Cancer Inst, 1990; 82: 34-39 doi:10.1093/jnci/82.1.34
12. KORBELIK M. AND DOUGHERTY G. Photodynamic therapy-mediated immune respose against subcutaneous mouse tumors. Cancer Res. 1999; 57: 1941-1946
13. GOLLNICK S., LIU X, OWEZAREZAK B., MUSSER D. A, HENDERSON B.W. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res. 1997; 57: 3904-3909
14. CANTI G., FRANCO P., MARELLI O. Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model Cancer Res. 1984; 44: 1551-1556,
15. KORBELIK M. Induction of tumor immunity by photodynamic therapy. J. Clin. Laser Med. Surg. 199617: 329-334,
16. CANTI G., LATTUADA D., NICOLIN A., TARONI P., VALENTINI G. et al. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocianine and laser light. Anticancer Drugs 1994; 5: 443-447
17. NICOLIN A., CANTI G., MARELLI O., VERONESE F., GOLDIN A. Chemotherapy and Immunotherapy of L1210 leukemic mice with antigenic tumor sublines. Cancer Res. 1981; 41: 1358-1362
18. MANN H.B., WHITNEY D.R. On test of whether one or two random variables is stochastically larger than the other. Ann. Math. Statist. 1947; 18: 52-54 doi:10.1214/ aoms/1177730491
19. HOPPER C. Photodynamic therapy with Foscan (temoporfirin) in primary squamous cell carcinoma of the head and neck. Proc. Int. Cong. On Head and Neck oncology, San Francisco, July 2000.
20. TAN IB. Foscan-mediated photodynamic therapy in recurrent and second primari oral cavità cancers. Laryngo-Rhino-Othology 2000; 79: 318-324
21. WENIG BL. Foscan-mediated photodynamic therapy in the palliative treatment of advanced heah and neck cancer. Proc. Am. Soc. Clin. Oncol. 2000; 19: 165-170
22. HOPPER C. Photodynamic therapy: a clinical reality in the treatment of cancer. The Lancet Oncology 2000; 1; 212-219 doi:10.1016/S1470-2045(00)00166-2
23. HIMES R.H. Interaction of the catharanthus (vinca) alkaloids with tubulin and microtubules. Pharmacol. Ther. 1991; 51: 256-261 doi:10.1016/0163-7258(91)90081-V
24. WANG D., LIPPARD S.J. Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov. 2005; 4: 307-320 doi:10.1038/nrd1691
25. KORBELIK, M. Induction of tumor immunity by photodynamic therapy J. Clin. Laser Med. Surg. 1996; 14: 329-334
26. CANTI G., CUBEDDU R., TARONI P., VALENTINI G. Photodynamic therapy with photoactivated aluminum disulfonated phthalocyanine and cellular immune response S.P.I.E. 1998; 3254: 12-18.